Skip to main content

Archived Comments for: Plasmatic level of neurosin predicts outcome of mild cognitive impairment

Back to article

  1. Practical parameter

    Carlos Vazquez Perez, HCUN

    10 February 2009

    So we can now predict with some precision the evolution of a group of MCI patients... That´s fantastic! This means that we can now easily say "this patient has a high likelihood to convert to vascular dementia, lets optimize his/her treatment including cardiovascular protective approaches".

    This is really a step forward in the current manage of MCI patients. I´d like to be provided with such a test in my clinical practice. Is it going to be commercialized?

    Competing interests